Showing results (1211-1220 of 1,735) with videos related to
Sort By:
Pageof 174
CNS Spectrums|March 17, 2017
Lurasidone for major depressive disorder with mixed features and irritability: a post-hoc analysisAlan C Swann, Maurizio Fava, Joyce Tsai, et al.CNS Spectrums|July 16, 2019
Allostatic load and the cannabinoid system: implications for the treatment of physiological abnormalities in post-traumatic stress disorder (PTSD)James B Lohr, Hang Chang, Michelle Sexton, et al.CNS Spectrums|March 28, 2019
A study on the correlates of habit-, reward-, and fear-related motivations in alcohol use disorderMarcelo Piquet-Pessôa, Samuel R Chamberlain, Rico S C Lee, et al.CNS Spectrums|October 6, 2016
Clinical management of restless legs syndrome in end-stage renal disease patientsZeyad T Sahli, Jae Jo, Shaker A Mousa, et al.CNS Spectrums|April 28, 2015
Crime, violence, and behavioral health: collaborative community strategies for risk mitigationDebra A PinalsCNS Spectrums|October 26, 2019
Pregabalin augmentation for resistant obsessive-compulsive disorder: a double-blind placebo-controlled clinical trialArash Mowla, Mehrnoosh GhaedsharafCNS Spectrums|August 18, 2016
Effects of aripiprazole once-monthly on symptoms of schizophrenia in patients switched from oral antipsychoticsTimothy Peters-Strickland, Cathy Zhao, Pamela P Perry, et al.CNS Spectrums|July 16, 2016
Psychotic disorders in DSM-5 and ICD-11Falko Biedermann, W Wolfgang FleischhackerCNS Spectrums|April 12, 2021
In (deficit) schizophrenia, a general cognitive decline partly mediates the effects of neuro-immune and neuro-oxidative toxicity on the symptomatome and quality of lifeMichael Maes, Buranee KanchanatawanPageof 174